Crystal form of Ticagrelor Brilinta and preparation method and purpose thereof

The invention discloses for a novel crystal form of Ticagrelor Brilinta, and a preparation method and purpose thereof in preparing medicaments for reducing arterial thrombosis in patients with acute coronary syndrome.

Saved in:
Bibliographic Details
Main Authors REN FANGJUN, SHENG XIAOXIA, SHENG XIAOHONG, HU CHENYANG
Format Patent
LanguageChinese
English
Published 15.10.2014
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention discloses for a novel crystal form of Ticagrelor Brilinta, and a preparation method and purpose thereof in preparing medicaments for reducing arterial thrombosis in patients with acute coronary syndrome.
Bibliography:Application Number: CN201310118496